Suite A · 6450 Kingston Pike, Knoxville TN 37919  ·  (865) 895-9118

Home  /  Weight Loss  /  GLP-S & GLP-T

GLP-1 Therapy

The medication is powerful. The protocol is the difference.

GLP-S (semaglutide) and GLP-T (tirzepatide) have transformed what medical weight loss can deliver. Our job is to get the most out of them, safely, for you.

Choose your protocol

Two medications, two dedicated protocol pages. Read the one that fits where you are — or call and we’ll help you choose.

The shared protocol

GLP-1 receptor agonists — semaglutide and tirzepatide — are the most effective medical weight-loss tools ever brought to market. In our hands, they routinely deliver sustained, measurable results patients had stopped believing were possible: meaningful weight loss, better blood-sugar control, improved cardiovascular markers, and — for many — the lift in energy and mood that comes with feeling in command of their body again.

Who it’s for

Adults ready for a medical-grade approach to weight loss — patients with hypothyroidism, polycystic ovary syndrome, post-menopausal weight gain, insulin resistance, or the more common story: a metabolism that simply isn’t responding to the strategies that used to work. If you’ve put in the effort and the results haven’t followed, this is where we begin.

What sets our protocol apart

A full metabolic baseline before dose one

Every patient starts with a complete workup — fasting glucose, A1C, lipid panel, comprehensive metabolic panel, thyroid, sex hormones where indicated, vitamin D, B12. We design your protocol around what your body is actually doing, not a generic dosing chart.

Pharmaceutical-grade sourcing

Every dose comes from FDA-regulated, U.S.-licensed pharmacies. The molecule in your vial is the molecule on the label — every time.

Lean tissue is the metric that matters

Sustainable weight loss is body-composition loss, not just scale loss. We pair every GLP protocol with nutrition guidance focused on protein adequacy and clear resistance-training direction — because the body you build during the medication phase is the body you keep after.

An exit plan, designed from day one

Most patients do not stay on GLP medications indefinitely. We design tapering and maintenance protocols from the start, so the transition off the medication — and life after — is built into the plan from your first visit.

What to expect

Begin with a conversation

Every patient starts with a private consultation and a clinical workup. We’ll talk through your goals, build a protocol that fits, and walk you through the timeline week by week. By appointment.

Call (865) 895-9118 Request a Consultation

Sources

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002. pubmed.ncbi.nlm.nih.gov/33567185
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216. pubmed.ncbi.nlm.nih.gov/35658024

Text Us

Leave us a message — we’ll text you back same business day.

By submitting you agree to be contacted about your inquiry.